NURS FPX 4055 Assessment 4 Health Promotion Plan Presentation

Name

Capella university

NURS-FPX4055 Optimizing Population Health through Community Practice

Prof. Name

Date

Health Promotion Plan Presentation

Good morning, everyone. We are glad partners have joined today’s session. This session is about preventing Human Papillomavirus (HPV) infection in adolescents and young adults between the ages of 11 and 26, in Schwenksville, Pennsylvania. Today’s presentation will provide information about HPV and its relation to cancer, its benefits to timely immunization, and strategies for talking to healthcare providers and family members about HPV vaccination. This presentation is guided by the SMART goals we developed as an agreement and the Healthy People 2030 objectives. We will now proceed to the presentation roadmap.

Presentation Roadmap

Throughout the presentation, we will:

Provide key facts about HPV, its transmission, and its link to cancer.
Explain the importance, safety, and effectiveness of the HPV vaccine.
Encourage participants to commit to scheduling the HPV vaccination within 30 days.
Build participants’ confidence in discussing the HPV vaccine with healthcare providers and family members.
Engage participants through interactive activities and discussions.
Evaluate participant knowledge and confidence through a brief post-session quiz and survey.

Key Information About HPV and Its Link to Cancer

HPV is a very common virus that spreads from person to person through skin-to-skin contact, mainly through sexual activity. The statistics show that in Pennsylvania, only 68.7% of adolescents are fully vaccinated against HPV-related cancers. Specifically, these vaccination rates are low in rural areas (48.7%), like Schwenksville, with high HPV-associated cancer incidence and mortality rates (PA.gov, 2025). Thus, vaccine awareness and implementation are crucial in Schwenksville.

HPV is also a major cause of cervical, anal, throat, and genital cancers. Persistent HPV infections, especially infections with high-risk strains such as HPV 16 and 18, can result in abnormal cell changes that end up as cancer (Huber et al., 2021). However, early detection is crucial because these infections can persist for years without symptoms. HPV is spread through sexual contact, and although most infections go away on their own, those that last can cause serious harm to cells and increase cancer risk. The best way to prevent high-risk HPV infections and to significantly decrease one’s chances of getting HPV-related cancers is through vaccination. Vaccination is indispensable, and so are regular screenings, in fighting the cancer burden associated with HPV.

Benefits of Timely HPV Vaccination

HPV vaccination is a powerful tool to prevent certain types of cancers and genital warts if given on time. The vaccine works best when given at a young age, such as at about 11 or 12, before the person is exposed to the virus sexually. Early vaccination has several benefits. These include:

It allows the immune system to respond optimally, and protection lasts long term against HPV related diseases (Hoes et al., 2021). Vaccination at a young age guarantees that the immune system will respond the most effectively with a stronger and longer-lasting immune response. Giving the vaccine before someone is exposed to HPV is extremely effective at preventing future HPV-related health problems and at keeping the risk from ever happening after exposure to HPV.
The second most frequent cancer in women globally is cervical cancer, which can be avoided with prompt HPV vaccination (Huber et al., 2021). HPV primarily causes cervical cancer. Early vaccination against the virus prevents the most dangerous strains of the virus, which reduces the risk of cervical cancer in women. Vaccinating girls at a young age will reduce incidences of cervical cancer, and therefore improve the long-term health of women worldwide.

NURS FPX 4055 Assessment 4 Health Promotion Plan Presentation

It also helps to reduce the risks of other HPV-related cancers in both men and women, such as anal, penile, and oropharyngeal cancers (Cheng et al., 2020). Vaccinating adolescents will reduce the future burden of these cancers to dramatically healthier individuals and communities.
In addition to cancer prevention, the HPV vaccine also helps prevent genital warts. Certain strains of HPV can cause genital warts that are painful and may lead to emotional distress. HPV warts are prevented by vaccinating adolescents, as it reduces the amount of genital warts and alleviates social stigma and the psychological effects of the condition.
Timely vaccination helps to stop the spread of HPV. Adolescent vaccination at an early age reduces the overall prevalence of HPV in the community. The more vaccinated people, the less likely the virus will spread, given that some may not be vaccinated or are immunocompromised. However, this collective immunity allows the community to be immune to HPV-related diseases (Xu et al., 2024).

Strategies for Discussing HPV Vaccination

Discussing HPV vaccination with healthcare providers and family members requires effective communication. Here are three ways to set up these conversations.

Using Evidence-Based Facts: People can provide reliable fact-based information from trusted sources such as the CDC or the WHO. Sharing statistics on how effective the HPV vaccine is at preventing cancer and how safe it is can offer a firm base of conversation and debunk the misinformation.
Asking Informed Questions: During discussions, one can ask thoughtful and informed questions, such as ‘What are the long-term benefits of the HPV vaccine?’ or ‘What do you think the vaccine could do to my health?’ This will promote open dialogue and help get to the root of the topic (Kassymbekova et al., 2023).
Addressing Common Myths: Individuals can share common misconceptions, and providers can respond by calmly explaining factual information. For instance, when confronted with the myth that the vaccine encourages early sexual activity, providers can explain that the vaccine’s purpose is to prevent cancer and other HPV-related diseases, not to push for behavior.

Developed SMART Goals with the Participants

I appreciate your attention so far. We’ve discussed the information to lay a strong foundation for HPV prevention. We will now go through the SMART goals we had developed earlier to guide our session and indicate progress. The goals were as follows:

Firstly, by the end of today’s session, we aim for 90% of you to correctly identify at least three key facts about HPV and its connection to cancer. We’ll check your understanding with a quick quiz activity.
Secondly, we hope that at least 80% of you are confident enough to commit to scheduling the first dose of the HPV vaccine within the next 30 days, using the resources we’ll provide.
Thirdly, we want 85% of you to leave feeling more confident discussing HPV vaccination with healthcare providers and family members. To help you feel ready, we’ll practice using evidence-based facts, asking informed questions, and addressing common myths.

These goals are about giving you the knowledge to empower you with that knowledge and encouraging action to empower you to advocate for your health and community.

Session Evaluation on Developed SMART Goals

The educational session was very successful in attaining our SMART goals. Of the 92.5% who answered correctly that they know three or more key facts about HPV and its link to cancer, we met our first goal. Many participants actively participated with the material and asked insightful questions during the talks. For the second goal, 75% of eligible participants verbally committed to scheduling the HPV vaccine within 30 days, but this was not enough for 80%. Finally, we reached our third goal as 85% of participants reported higher confidence in discussing HPV vaccination.

Nevertheless, some problems were found. Several participants, mainly teenagers, were uncertain about making immediate vaccination pledges and opted to have more time to discuss with their families. In addition, some participants increased in confidence, but four expressed discomfort about tackling common myths without more support. As a result of these observations, several changes would benefit future sessions.

NURS FPX 4055 Assessment 4 Health Promotion Plan Presentation

One way to improve commitment rates would be to enable earlier opportunities for participants to discuss vaccination with a family member during the session. Second, giving more structured role-playing activities and myth-busting practice could make participants even more confident in dealing with misinformation. Third, the session could be extended slightly, or a follow-up meeting could offer more time for hesitant families to make an informed decision. This will better meet participant needs and improve the overall effect of future educational efforts.

Session Evaluation on Healthy People 2030 Objectives

The instructional session achieved the goals of Healthy People 2030. Increasing the percentage of teenagers who receive the necessary doses of the HPV vaccine and focusing on the vaccine types covered are two ways to lower the number of HPV infections in young adults (U.S. Department of Health and Human Services, n.d.). The health objectives about raising vaccination rates were directly supported by most participants’ increased understanding of HPV, its connection to cancer, and the significance of prompt immunization. Positive steps on the empowerment of communities to make informed preventive health decisions have been evidenced in the 92.5% of knowledge attained and an 85% improvement in communication confidence.

Although the vaccine initiation rate commitment fell short of 80%, only 75% of the participants committed to vaccine initiation. This points to a gap in supporting the alignment with Healthy People 2030’s call for early vaccination to prevent HPV related cancers. Furthermore, some participants continued to be uncertain and misinformed about vaccine safety and require more rigorous myth-busting education to fully achieve national health promotion goals.

To align future sessions with Healthy People 2030 goals, revisions are needed. In future sessions, there should be opportunities for extended family engagement, discussions about vaccine safety backed by current evidence, and follow-up communications to reinforce the importance of vaccination. It may also increase trust and uptake (Xu et al., 2024). The changes will help the session achieve national objectives and increase immunization among adolescents and young adults.

Conclusion

Overall, this session concluded with the concept that HPV vaccination is essential to prevent cancer and improve long-term health in adolescents and young adults of Schwenksville, PA. It’s a process of increasing awareness, timely vaccinations, and better messaging to one another. Learning was guided by the SMART goals we developed, and there were still growth areas. We were pleased with the strong intuitive knowledge gains and felt we could improve for the future session. We are closer to reaching the Healthy People 2030 objectives and strengthening our community by committing to health actions through education.

References

Cheng, L., Wang, Y., & Du, J. (2020). Human papillomavirus vaccines: An updated review. Vaccines, 8(3), 391. https://doi.org/10.3390/vaccines8030391

Hoes, J., Pasmans, H., Schurink-van ’t Klooster, T. M., van der Klis, F. R. M., Donken, R., Berkhof, J., & de Melker, H. E. (2021). Review of long-term immunogenicity following HPV vaccination: Gaps in current knowledge. Human Vaccines & Immunotherapeutics, 18(1). https://doi.org/10.1080/21645515.2021.1908059

Huber, J., Mueller, A., Sailer, M., & Regidor, P.-A. (2021). Human papillomavirus persistence or clearance after infection in reproductive age. What is the status? Review of the literature and new data of a vaginal gel containing silicate dioxide, citric acid, and selenite. Women’s Health, 17, 174550652110207. https://doi.org/10.1177/17455065211020702